Levothyroxine Starting Dose for Adults with Hypothyroidism
The recommended starting daily dosage of levothyroxine for adults with primary hypothyroidism is 1.6 mcg/kg/day for most patients without cardiac disease or risk factors. 1, 2, 3
Initial Dosing Based on Patient Characteristics
- For adults without cardiac disease or significant comorbidities, a full replacement dose of 1.6 mcg/kg/day is safe and effective 1, 4
- For adults >70 years or with cardiac disease/multiple comorbidities, start with a lower dose of 25-50 mcg/day and titrate gradually to avoid exacerbating cardiac symptoms 1, 2
- For patients at risk of atrial fibrillation or with underlying cardiac disease, use a lower starting dose and titrate more slowly (every 6-8 weeks) 2
Dose Considerations for Special Populations
- For pregnant women with pre-existing hypothyroidism, monitor TSH every 6-8 weeks and adjust dosage to maintain TSH within trimester-specific reference ranges 5
- For patients with secondary or tertiary hypothyroidism, use serum free-T4 levels (not TSH) to guide therapy, aiming for the upper half of the normal range 2
- For patients with TSH >10 mIU/L, treatment is recommended regardless of symptoms due to higher risk of progression to overt hypothyroidism 1
Monitoring and Titration
- After initiating therapy, monitor TSH every 6-8 weeks while titrating the dose 1
- Adjust dosage by 12.5-25 mcg increments every 4-6 weeks until the patient is euthyroid 1, 2
- The peak therapeutic effect may not be attained for 4-6 weeks after a dose adjustment 2
- Once adequately treated, repeat testing every 6-12 months or if symptoms change 1
Administration Guidelines
- Administer levothyroxine on an empty stomach, at least 30 minutes before breakfast for optimal absorption 6
- Take separately from other medications that may impair absorption 2, 6
- For patients who cannot swallow tablets, crush the tablet and suspend in a small amount of water for immediate administration 2
Common Pitfalls to Avoid
- Undertreatment risks persistent hypothyroid symptoms, adverse effects on cardiovascular function, lipid metabolism, and quality of life 1
- Overtreatment can lead to iatrogenic hyperthyroidism, increasing risk for osteoporosis, fractures, abnormal cardiac output, and ventricular hypertrophy 1
- About 25% of patients on levothyroxine are unintentionally maintained on doses sufficient to fully suppress TSH, highlighting the importance of regular monitoring 1
- Absorption may be impaired by medications that increase gastric pH or by certain foods like soybean-based products 2, 6